MedTrace Logo

Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients

NCT03596944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2018-09-12

No results posted yet for this study

Summary

This study aims to evaluate the effect of statin for primary prevention, towards lowering the incidence of recurrent myocardial infarction, cardiogenic shock and mortality in ACS patients.

Conditions

  • Acute Coronary Syndrome
  • Recurrent Myocardial Infarction
  • Cardiogenic Shock

Interventions

DRUG

Statin

Prescribed with statins for primary prevention

Sponsors & Collaborators

  • Cengkareng General Hospital

    collaborator OTHER

  • Tarumanagara University

    lead OTHER

Principal Investigators

  • Angela F Sunjaya · Tarumanagara University

  • Anthony P Sunjaya · Tarumanagara University

  • Andria Priyana, MD, FIHA · Department of Cardiology, Faculty of Medicine, Tarumanagara University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-06-30
Completion
2018-08-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03596944 on ClinicalTrials.gov